Top-line Sales Growth
Global sales of $3.4 billion, up 6.3% year-over-year (2.5% internal/local currency, 3.1% favorable foreign exchange, 0.7% acquisitions).
Profitability Improvement on a Non-GAAP Basis
Non-GAAP operating margin expanded to 7.53%, up 28 basis points year-over-year; non-GAAP net income rose to $153 million ($1.32 diluted EPS) from $143 million ($1.15), reflecting margin and mix improvements.
Adjusted EBITDA Growth
Adjusted EBITDA of $289 million in Q1, up 11.6% versus $259 million in Q1 2025.
Strong Performance in High-Growth Businesses
U.S. Dental, Global Technology and value-added services showed robust growth (Global Tech sales +7.0%, Global value-added services +10.6% (7.8% LCI)). High-growth, high-margin businesses now approaching ~50% of operating income and on track to exceed 50% by 2027.
Cloud & Software Momentum
Cloud-based customers increased roughly 25% year-over-year to more than 13,000 Dentrix Ascend and Dentally subscribers; Dentrix Ascend and other software businesses reported strong revenue growth.
E-commerce Adoption
Major rollout progress for henryschein.com: over 80% of U.S. dental e-commerce sales now transacted on the platform; Canadian and U.S. lab rollouts completed; U.S. rollout expected to finish by end of August.
Capital Return and Balance Sheet Actions
Repurchased ~1.6 million shares in Q1 at an average price of $77.64 for $125 million; approximately $655 million remaining authorization for future buybacks.
Value Creation Targets and Early Execution
Company reaffirmed target of >$200 million annual operating income improvement over multi-year horizon with $125 million run rate by end of 2026; early cost and gross-profit initiatives underway (outsourced back-office, indirect procurement savings, value pricing, corporate brand growth).